use of patient-reported outcome measures rather than anthropomorphic measurements or measurement scales scored by clinicians. 2 This is in part because previous studies have found little correlation between clinician-reported and patientreported aesthetic satisfaction following such surgery and partly because of a recognition that the patient should be the ultimate judge of subjective outcomes such as aesthetic appearance. 5, 6 Numerous studies have evaluated patientreported outcomes following different types of breast reconstruction in populations of between 45 and 2328 women. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] However, these studies demonstrated methodologic weaknesses in one or more of the following areas: inadequate length of followup; a failure to include immediate reconstruction and delayed reconstruction patients, the full range of reconstructive techniques, and all eligible centers; lack of a prospective design; a lack of case-mix adjustment; a lack of validated and surgery-specific scales; and a failure to formally calculate outcome scores for these scales to enable valid comparisons.
We undertook a national prospective cohort study that examined patient-reported outcomes after mastectomy and breast reconstruction surgery for women treated in England, Scotland, and Wales. 16 The study collected data from women undergoing immediate or delayed reconstruction procedures using a set of validated surgery-specific scales that have been used widely to evaluate the outcomes of breast reconstruction. 2, 17 In this article, we compare the outcomes of six different reconstructive techniques.
PATIENTS AND METHODS

Treatment Sites and Inclusion Criteria
During the 15-month recruitment period from January 1, 2008, to March 31, 2009, all 150 English National Health Service acute hospital trusts providing acute breast cancer treatment, six National Health Service acute trusts in Wales and Scotland, and 114 independent hospitals in England participated in the study. Treatment sites were asked to prospectively collect and record clinical data on women aged 16 years and older with a diagnosis of invasive carcinoma of the breast or ductal carcinoma in situ undergoing mastectomy surgery with immediate or primary delayed reconstruction following a previous mastectomy, and to obtain written consent from eligible women to allow them to be sent follow-up questionnaires. National Cancer Audits are exempt from the United Kingdom National Research Ethics Committee approval process. Approval to prospectively collect patient data for analysis and reporting was obtained from the Patient Information Advisory Group under Section 60 of the Health and Social Care Act 2001.
Reconstructive Procedure Types
We compared six different surgical techniques: tissue expander or breast implant alone; pedicled latissimus dorsi flap combined with an expander or implant (latissimus dorsi with implant/expander); latissimus dorsi flap alone (autologous latissimus dorsi); pedicled transfer of a transverse rectus abdominis myocutaneous flap (TRAM); free tissue transfer of this flap (free TRAM); or a free tissue transfer of a similar flap without the underlying muscle, based on the deep inferior epigastric artery perforator (DIEP) or superficial inferior epigastric artery (SIEA). The remaining patients had a flap of skin and fat with or without muscle taken from the upper or lower buttock or inner thigh regions (superficial gluteal artery perforator, inferior gluteal artery perforator, or transverse upper gracilis) but were excluded from our analyses because of the extremely small numbers enrolled.
Clinical Data Collection
A range of data items were recorded by clinicians for each patient. These included details of surgical procedures, patient clinical and sociodemographic characteristics, and consent status. The full data set is available at https://www.rcseng.ac.uk/surgeons/ research/ceu/copy_of_docs.html.
Patient Questionnaires
The postreconstruction questionnaires addressed patient satisfaction with their breast area appearance (16 items, with an additional two for implant patients), which we believe to be synonymous with aesthetic outcome from the patient's perspective, along with emotional well-being (10 items), physical well-being (16 items), sexual well-being (six items), and the outcomes of surgery (seven items). The scales were derived from the BREAST-Q, 2 and were pretested with English breast cancer patients by the authors before their use to ensure that there were no issues with language, comprehension, or acceptability. Copies of the full questionnaires are available at https://www.rcseng.ac.uk/surgeons/ research/ceu/copy_of_docs.html.
Questionnaire Administration and Collection
Clinicians were asked to obtain consent from any eligible women at the time of surgery to allow follow-up questionnaire administration. The questionnaires were sent to patients who had given consent at their home address 18 months after surgery by a coordinating team of researchers that did not include the treating hospitals or clinicians, once the team had confirmed the patient was still alive by cross-checking their details against mortality data held by the National Strategic Tracing Service. A prepaid envelope was enclosed to facilitate return of the completed questionnaire. Questionnaires were marked only with a unique numeric patient identifier. Nonrespondents were sent a single reminder letter and an additional copy of the questionnaire at a 5-week interval.
Statistical Analysis and Multiple Linear Regression Model
Patients' responses were entered into a database and then transferred to a bespoke Q-Score software package to calculate scores for each BREAST-Q scale, with 0 being the lowest and 100 being the highest possible scores. 2 Patient scores were linked to their associated clinical data using their unique numeric identifier.
Separate linear multiple regression models were developed for the immediate and delayed reconstruction patient groups, and were used to predict the outcome scores for each BREAST-Q scale (dependent variables) based on patient characteristics and reconstructive procedure type. The preliminary models included only patients with complete outcome and case-mix data, and were constructed using a backward stepwise process with variables dropped from the models if the strength of their association with an outcome was weak (Wald test for variable inclusion, p < 0.05). Variables were included in continuous or categorical format depending on their type. The casemix variables included sociodemographic items (i.e., age, a geographically assigned measure of socioeconomic deprivation, and hospital of treatment), patient factors known to affect subsequent morbidity (i.e., smoking status, body mass index, diabetes status, American Society of Anesthesiologists grade, and Eastern Cooperative Oncology Group performance status), and tumor characteristics (i.e., invasive status and Nottingham Prognostic Index). [18] [19] [20] [21] Deprivation in England is measured by the government using seven distinct domains or indicators of poverty (i.e., income; employment; education, skills, and training; health; crime; barriers to housing and services; and living environment) that are weighted before a deprivation score and rank are produced for each geographic area (super output area, a small local population of a few thousand people).
The Eastern Cooperative Oncology Group functional status categorical scoring system is an American measure used internationally to measure the functional status of patients undergoing cancer treatments. It is also known as the World Health Organization or Zubrod score.
The models were then used to produce adjusted means and confidence intervals for each scale score, by procedure type, which demonstrated the effect size. Finally, the Wald test was undertaken for the type of reconstructive procedure to examine the heterogeneity of outcomes across different types of reconstruction and determine whether or not the differences in means were attributable to chance alone.
All statistical tests were two-sided, and values of p < 0.05 were considered to represent a statistically significant result. All statistical analyses were undertaken using STATA/MP 14 (StataCorp, College Station, Texas) and Microsoft Excel (Microsoft Corp., Redmond, Wash.) software.
RESULTS
Patient Population
Within the study cohort, 3349 patients underwent immediate reconstruction. Of these, 43 did not have their consent status for the follow-up study recorded, 35 were deemed incapable of completing a written questionnaire in English, and 1148 were not asked to participate because of difficulties with the recruitment process at some hospitals. Of the remaining 2123 women, 1939 gave their consent and 1528 returned a completed questionnaire. After excluding 144 women for whom complete case-mix data were not available, responses from 1384 were included in our final analyses. Questionnaires were completed 586 days after surgery, on average, with an interquartile range of 30 days.
There were 1714 patients who underwent delayed reconstruction. Of these, nine did not have their consent status for the follow-up study recorded, six were deemed incapable of completing a written questionnaire in English, and 609 were not asked to participate. Of the remaining 1090 asked to participate, 984 gave their consent and 761 retuned questionnaires. A further 28 patients were excluded because of incomplete case-mix data; this left 733 for our final analyses. The mean length of time between a patient's mastectomy and their subsequent delayed reconstruction procedure was, on average, 2.8 years (range, 0 to 32 years). There were small differences in the mean time to delayed reconstruction by procedure type, varying from 2.4 years (latissimus dorsi flap with implant) to 2.9 (free flap) and 3.0 years (implant/expander-only). Questionnaires were completed 582 days after surgery, on average, with an interquartile range of 26 days. Table 1 summarizes the consent and response rates for the different reconstruction techniques. Table 2 displays the sociodemographic and clinical characteristics of the women who underwent each type of procedure. Patients undergoing different procedures were generally similar. Those characteristics that were significantly associated with the outcomes under investigation were included in the two separate multiple linear regression models used subsequently to derive final case-mix adjusted scores for the respective patient groups. During the model development process, the characteristics significantly associated with outcomes were ethnicity, deprivation level, American Society of Anesthesiologists grade, and tumor burden for immediate reconstruction patients; and ethnicity, Eastern Cooperative Oncology Group score, and diabetes status for those undergoing delayed reconstruction. The other characteristics examined (including age, radiotherapy, chemotherapy, smoking status, and body mass index) were not independently associated with outcomes and were not therefore included in the final models. The immediate reconstruction patients were of similar age and functional status to those undergoing delayed reconstruction, but were less likely to be from a white ethnic group or the most deprived quintile, or to have a high American Society of Anesthesiologists grade or diabetes. Immediate reconstruction patients were also much more likely to have a low tumor burden (ductal carcinoma in situ or low-risk invasive). Figure 1 presents the immediate and delayed reconstruction procedure-specific unadjusted mean scores for each of the five BREAST-Q scales, along with the associated 95 percent confidence intervals. With respect to breast area appearance, in the immediate reconstruction group, women who underwent a pedicled TRAM flap procedure had the highest outcome scores. However, the sample size for this group was relatively small (n = 34) and thus the precision associated with this estimate is relatively poor. The other patient groups who underwent a flap reconstruction (with or without implant) also had relatively high scores. The lowest breast area appearance scores were associated with patients who underwent expander or implant-only reconstruction. In the delayed reconstruction group, free TRAM flaps, DIEP flaps, and then the other types of flap-based reconstruction (with or without implant) were associated with the highest breast area appearance scores. Again, the expander or implant-only patient group had the lowest scores.
Patient Characteristics across the Surgical Groups
BREAST-Q Scores for Each Procedure
After adjustment for patient characteristics, there were persistent differences in the outcomes achieved by the procedure groups, with the exception of physical well-being. Tables 3 and 4 show the adjusted differences in the mean scores for each scale, using the expander/implant group as the reference category. In both the immediate and delayed reconstruction settings, all flap-based procedures resulted in higher scores on all scales other than physical well-being. The only exception to this pattern was for the immediate reconstruction pedicled TRAM flap group.
DISCUSSION
Key Findings
Women who underwent reconstruction tended to be satisfied with the results of the procedure, with mean overall satisfaction scores of 71.1 (95 percent CI, 69.8 to 72.4) for immediate reconstruction procedures and 79.3 (95 percent CI, 77.7 to 81.0) for delayed reconstruction procedures. Patients who underwent autologous reconstruction reported higher scores than those women who had an expander or implant alone, in both the immediate and delayed reconstruction settings, across four of the five scales. For immediate procedures, the size of these differences was typically between 1 and 7 points. For delayed procedures, the difference between the scores tended to be between 7 and 15 points. 22 To interpret the magnitude of these differences, it is useful to compare them to a cohort of patients who underwent mastectomy alone over the same period at the same group of hospitals. 16 These patients recorded a mean score of 56 on the breast area appearance scale, which is similar to the mean unadjusted score recorded for implant-only patients recorded in this study but between 8 and 21 points lower than that recorded for patients undergoing autologous immediate reconstruction procedures. A similar pattern was seen for Emotional Well-being (1-point difference for implant-only; 5-to 16-point difference for autologous procedures) and Sexual Well-being (7-point difference for implant-only; 13-to 28 -point difference for autologous procedures), whereas Physical Well-Being scores were similar in those who underwent mastectomy or any form of immediate reconstruction. There is no agreed definition of what constitutes a clinically important difference for the BREAST-Q scales used in our study, but a difference of approximately 10 points on each scale may be taken to be equivalent to a moderate effect size using Norman's standard formula of 0.5 SD. 23 We would caution that these results should not be interpreted as a prescriptive indication in favor of one set of procedures over another. We were not able to collect data on women's perspectives on what might have led them to select one type of reconstruction over another. Consequently, we have no way of taking into account their baseline expectations or the influence of their preferences for the level of surgical insult they were willing to endure. We therefore suggest that the results should only be used to inform women of the outcomes they might expect to achieve with different treatment scenarios and should be used alongside information about the surgical approach, complication rates, and recovery time.
Strengths and Limitations
Our study had a number of strengths. First, we used specifically developed and previously validated outcome measures that were distributed centrally at a standardized follow-up interval of 18 months, to ensure that the great majority of women had completed any adjuvant treatments and secondary reconstructive procedures requi red. 2, 17, 22, 24, 25 Second, we examined outcomes for a national population that was recruited prospectively, with explicit written consent obtained before inclusion. Third, we had excellent response rates of close to 80 percent. Fourth, we included women with failed reconstructive procedures within the study to minimize bias. Fifth, to minimize the risk of confounding, we undertook robust case-mix adjustment within a multiple linear regression model that included all factors that significantly affected our study outcomes. This adjustment had little effect on the outcome scores of each scale, suggesting that our procedure-specific comparisons were safe and robust. There were also some weaknesses. Although the overall sample of approximately 1500 immediate reconstruction and 700 delayed reconstruction patients was large compared with other studies in this field, the size of certain subgroups (e.g., those who had a pedicled TRAM flap) was relatively small, with wide confidence intervals and an increased risk of sampling bias.
Next, not all eligible women were asked to participate in the study, and it was not possible to estimate the recruitment rates for specific procedures. It is possible that recruitment was higher for certain procedures and that this has introduced a bias to the estimated outcomes we have recorded. However, there is no obvious reason why recruitment may have been higher for certain procedures, and the diffusion of patients in different procedure groups across a very large number of hospitals makes it unlikely that variable recruitment introduced a systematic error to our findings.
There was also the potential for heterogeneity of outcome across the large number of hospitals we included in the study. However, we included the identity of these organizations as a variable in our regression models to adjust for any organization-level clustering. Finally, our comparisons do not include recently developed reconstructive techniques such as lipomodeling and acellular dermal matrix and dermal sling procedures that were not widely used during the study period.
Interpretation of Our Findings
This study is consistent with a growing body of evidence that reconstruction using patients' own tissues is associated with better aesthetic outcomes than reconstruction using only an implant or expander. [6] [7] [8] [9] [10] [11] [12] [13] [14] There are a number of explanations for why autologous procedures are associated with superior aesthetic outcomes.
An implant or expander on its own can replace the volume that has been lost during mastectomy but cannot fully reconstitute the breast mound with respect to its shape or position on the chest wall. They are also static devices that will not adjust or change automatically with a patient's body habitus. Implants generally do not produce natural ptosis of the breast, as they adhere to the chest wall and cannot be positioned to extend below the inframammary fold, unlike native breast tissue or a flap. An implant can usually only be placed safely under mastectomy skin if covered by an additional layer, whether muscle or, alternatively, an acellular dermal matrix or dermal flap or sling. If not using a flap, the standard approach is to place an expander under the pectoralis major and stretch the muscle out, as otherwise the muscle is inadequate in terms of coverage and leaves the lower pole of the implant exposed. Using a submuscular implant or expander placement without breast tissue to provide additional cover means that the final breast mound shape achieved is difficult to control and predict. Although this may be less of an issue with bilateral reconstruction, our study included only those women with unilateral reconstruction whose contralateral breast was preserved.
Finally, implants lead the body to form a capsule of scar tissue around them. This capsular tissue contracts in a significant proportion of patients, more commonly following radiotherapy. An implant with a contracted capsule sits proud on the chest wall and may cause pain in addition to distortion. These implants may need to be removed or exchanged with capsule management (excision or release) at more frequent intervals for those women who are worst affected, resulting in a lifetime of additional procedures for some.
In contrast, using fat with or without muscle and skin from the back, abdomen, buttock, or thigh (a flap) has a number of advantages. First, because they consist of the patient's own tissues, they grow and shrink with the patient, and the contralateral breast, as their weight changes. Second, as flap constituents are similar to the breast tissue excised, they are better able to mimic the contralateral breast's natural shape, ptosis, and movement. Third, infection risk is much lower, as the tissues have an intact or restored blood supply and can respond to pathogens in a normal manner. Fourth, there are no capsular issues, and the reconstruction, if primarily successful, is definitive and lasts for life in most cases without the need for replacement.
The principal disadvantage of flap-based reconstruction is the need for a flap donor site that will inevitably be left with a scar, and sometimes with a contour defect, muscle weakness or bulge, sensory changes, or another type of longstanding or permanent morbidity. Another disadvantage is that these procedures are usually longer in duration and may expose patients to a higher risk of distant and systemic complications.
If an implant is used in combination with a flap (e.g., in the latissimus dorsi with implant group), the flap provides many of the advantages mentioned above, and ameliorates some of the aesthetic limitations of implant-only reconstruction by providing soft-tissue coverage and a more natural shape, and allowing definitive implant placement without the need for a temporizing expander. This is reflected in the high outcomes scores associated with such procedures, which in this study were comparable to those for autologous flap reconstruction. However, the patient is left with both a degree of donor-site morbidity and the need for capsule management and implant replacement over time.
Implications for Clinical Practice
Clinicians should ensure that women are provided with appropriate and adequate information about all breast reconstruction options as part of the decision-making process, including our principal finding that autologous procedures are associated with better aesthetic outcomes.
Our case-mix findings suggest that although there may be some selection of reconstructive procedure type by indication, the populations undergoing different procedures are broadly comparable. This suggests that many women who undergo implant-based reconstruction may also be suitable for flap-based reconstruction. Although not all women would choose autologous procedures because of their greater complexity, longer duration, donor-site morbidity, and higher overall complication rates, they should be informed that implant-based procedures are not without risks, particularly implant failure, 16 and have now been shown to be associated with lower patient-reported outcome scores.
CONCLUSIONS
Women who accessed autologous techniques tended to report greater satisfaction with their reconstruction than those who had an expander or implant. We recommend that clinicians act on our findings by providing all patients with appropriate written and verbal information regarding the full range of reconstructive options, including those not available at their treating hospital, and their associated patient-reported outcomes. 
